Kimberly-Clark Third Quarter 2026 Earnings Conference Call - KIMBERLY CLARK CORP

Explicit Guidance:

• FY 2026 Financials: Maintaining standalone Kimberly-Clark (KC) FY 2026 guidance despite one-off headwinds (China issues, fire) due to stronger underlying momentum and Q4 commercial agenda; expects full-year pricing to be relatively flat.
• FY 2027 Earnings: Expects adjusted EPS dilution of mid-single digits versus standalone KC FY 2027 baseline, driven by intangible asset amortization (not adjusted out in Non-GAAP); forecasts a "snapback" to profitable growth thereafter.
• FY 2027–2028 Outlook: Targets mid-to-high single-digit EPS growth on a two-year compounded basis versus 2026 standalone KC baseline starting in 2028.
• Synergy Financials: Full deal cost synergies targeted at $1.9 billion; excludes revenue synergies from this cost target.
• Inflation/Cost: Projects total full-year gross inflationary impact of approximately $250 million ($50M Q2, $200M remaining H2), driven by spot freight rate spikes; targeting cost-neutral pricing over time.
• Debt Metrics: Targeting leverage ratio of approximately 2x by the end of the second year post-transaction.

Business-Segment Outlook:

• North America: Confident in underlying health; expects performance improvement in H2/2027 despite recent share softness in baby care (club distribution changes) and postponed product launches (new asset quality issues). Tissue performing strongly with 20 bps share gains in Q3.
• China Diapers: Demand has stabilized and improved slightly following official safety clearance, but recovery is gradual ("bad news goes viral, good news does not"); expects business to remain subdued in Q4 with focus on rebuilding trust and regaining ~20% market leadership.
• Canview Integration:
  • OTC: Strong rebound; Tylenol up low-to-mid single digits YTD; Aleve/Nyquil up 7% YTD; Zyrtec up 5% YTD.
  • Hair Care: Rogaine up 30% YTD (driven by GLP-1 adoption link); OGX performing well.
  • Essential Care: Baby brands up 5% YTD; Band-Aid up 4% YTD.
  • Skincare: Underperformance (down ~1% YTD vs +4% category) due to assortment/creative issues; expects portfolio reset and increased marketing investment.
  • Oral Care: Down ~2% YTD; strategy to simplify offering and focus on category penetration.
• Product Launches:
  • New manufacturing asset launch postponed to early 2027 due to quality concerns.
  • "Big Dreams" diaper brand launch via Amazon partnership targeting value-oriented consumer segments (middle-to-lower income).
  • Q1 2027 launch of "HugFit 360" overnight diaper featuring enhanced diaper rash prevention technology.

Market and Competitive Outlook:

• Pricing Strategy: Total company pricing YTD down ~70-80 bps in NA; expects to land FY 2026 flat as Q3 lows lap the most intense promo period of prior year.
• Competitive Dynamics: Intense promotional environment in US; expects to compete via innovation and value propositions against lower-priced imports (e.g., Chinese diaper brands).
• Share Gains: Anticipate gradual return to category-level growth, particularly in new Canview categories, supported by increased marketing, R&D, and SKU rationalization.
• Channel Dynamics: E-commerce growth >20% (North America); working to resolve distribution issues in club channels for baby care.

Macro / Industry Outlook:

• Economic Environment: Operating strategy tailored for a "K-shaped" economy; focus on delivering best-in-class value across all tiers (premium to value) to maintain resilience.
• Inflation Trends: Freight rates remain a primary inflationary driver; relying on productivity (6.1% YTD) and revenue growth management to mitigate.
• Regulatory/Safety: China regulatory clearance (SAMR) confirmed product safety; government refuted false allegations, enabling trust-building efforts.

Strategic Initiatives:

• Acquisition Integration (Tenview): Completed; executing "Ready, Set, Grow" three-phase plan. "Ready" phase (first 100 days) focused on seamless operations and quick synergy wins; "Set" (2027) for foundation; "Grow" for full potential.
• Leadership Restructuring: Completed organizational alignment; "Ready" phase includes significant staffing changes throughout 2027 and phased ERP/SAP S4 integration (Canview systems to KC platforms).
• Capital Allocation: Reinvestment of ~$60% of revenue synergy value back into brands; cost synergies ($1.9B) intended to fund this reinvestment flywheel.
• Geographic Expansion: Leveraging Canview's strong distribution in Europe (e.g., personal care) and India (3.1M points of distribution) to expand KC brands where KC previously struggled.
• Joint Venture: ARBEX (with Susana) launched July 1; focus on cost containment, productivity, and supply chain optimization.

Risks and Headwinds to Outlook:

• China Recovery: Consumer trust rebuilding is time-consuming; 11/11 shopping festival impact expected to remain subdued in Q4 due to timing of safety news.
• Execution Risks: Quality issues with new manufacturing assets causing product launch delays; share loss in club channels for diapers requiring resolution.
• Inflation/Freight: Continued spot freight rate spikes could increase cost headwinds beyond $200M H2 estimate.
• Integration Complexity: Staffing changes, system cobbling (Power BI interim), and cultural alignment pose short-term operational risks.
• Revenue Synergies: Revenue synergy targets deemed "not written down" due to execution difficulty and necessary reinvestment; financial impact will be gradual.

Management Tone on the Future:

• Confidence: Highly confident in long-term value creation ("generational opportunity") and the "flywheel" model; describes integration as "boring" (stable operations) to contrast with excitement of the deal.
• Discipline: Emphasizes not sacrificing long-term value for short-term earnings management; willing to reinvest for future growth (e.g., China, China diapers, skincare reset).
• Tone Shift: Moves from "transformation mode" to "execution mode"; acknowledges 2027 will be conservative in outlook to allow room for investment and reset.
• Team Sentiment: Confident in the new leadership team (including Nelson and Jeff Malucci) and the ability to deliver synergies; optimistic about China team's capability.

Miscellaneous:

• Amortization Policy: Will continue to include intangible asset amortization in Non-GAAP metrics (unlike Canview's previous policy), causing the mid-single-digit dilution in 2027.
• Investor Events: Will provide detailed 2027 outlook and synergy cadence updates at CAGNY in February 2027.
• Divestiture: Departure of leader Russ Torres reflects mutual timing change for a new adventure, not a performance issue.